Back to Search
ANWAR RAZA, M.D.
M.D.
Anatomic Pathology Physician
NPI: 1831119387IndividualAccepts Medicare
Specialties, Licenses & Credentials
Neuropathology Physician
Pathology — Neuropathology
Code: 207ZN0500X
A53168(CA)
Anatomic Pathology PhysicianPrimary
Pathology — Anatomic Pathology
Code: 207ZP0101X
A53168(CA)
CMS Specialties
PrimaryPATHOLOGY
Education
OTHER
Class of 1983
Research & Publications (20)
Phase 1-2a multicenter dose-escalation study of ezatiostat hydrochloride liposomes for injection (Telintra, TLK199), a novel glutathione analog prodrug in patients with myelodysplastic syndrome.
PMID 19439093·J Hematol Oncol·2009
3-trial
Complete remissions observed in acute myeloid leukemia following prolonged exposure to lintuzumab: a phase 1 trial.
PMID 19557623·Leuk Lymphoma·2009
3-trial
Phase 1 multicenter dose-escalation study of ezatiostat hydrochloride (TLK199 tablets), a novel glutathione analog prodrug, in patients with myelodysplastic syndrome.
PMID 19398716·Blood·2009
3-trial
Characterization of a novel dithiocarbamate glutathione reductase inhibitor and its use as a tool to modulate intracellular glutathione.
PMID 19049979·J Biol Chem·2009
8-other
Design and synthesis of sulfoximine based inhibitors for HIV-1 protease.
PMID 18829317·Bioorg Med Chem Lett·2008
8-other
Combination of 5-azacytidine and thalidomide for the treatment of myelodysplastic syndromes and acute myeloid leukemia.
PMID 18720364·Cancer·2008
8-other
Phase 2 study of lenalidomide in transfusion-dependent, low-risk, and intermediate-1 risk myelodysplastic syndromes with karyotypes other than deletion 5q.
PMID 17893227·Blood·2008
3-trial
Development and application of spectrophotometric methods for the determination of citalopram hydrobromide in dosage forms.
PMID 16595940·Chem Pharm Bull (Tokyo)·2006
8-other
Phase II study of topotecan and thalidomide in patients with high-risk myelodysplastic syndromes.
PMID 16396766·Leuk Lymphoma·2006
3-trial
Remicade as TNF suppressor in patients with myelodysplastic syndromes.
PMID 15370256·Leuk Lymphoma·2004
3-trial
Arsenic trioxide and thalidomide combination produces multi-lineage hematological responses in myelodysplastic syndromes patients, particularly in those with high pre-therapy EVI1 expression.
PMID 15203277·Leuk Res·2004
5-case
Thalidomide produces transfusion independence in long-standing refractory anemias of patients with myelodysplastic syndromes.
PMID 11493439·Blood·2001
3-trial
What the human genome project will not tell us: the role of micro-organisms in disease.
PMID 11166834·Leuk Res·2001
8-other
Consilience across evolving dysplasias affecting myeloid, cervical, esophageal, gastric and liver cells: common themes and emerging patterns.
PMID 10634648·Leuk Res·2000
6-review
Myelodysplastic syndromes may have an infectious etiology.
PMID 11086944·J Toxicol Environ Health A·2000
7-preclinical
Anti-TNF therapies in rheumatoid arthritis, Crohn's disease, sepsis, and myelodysplastic syndromes.
PMID 10891888·Microsc Res Tech·2000
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 11370 ANDERSON ST, STE 2960
LOMA LINDA, CA 92354 - Phone
- (909) 558-6422
Quick Facts
- NPI
- 1831119387
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 43
- Publications
- 20
Are you this provider?
Claim Your Profile